TP53, encoding the tumor suppressive transcription factor p53, is not only the most frequently mutated genes in cancer but also across all types of lung cancer with mutations rates ranging from 46% in lung adenocarcinoma to over 90% in SCLC (Gibbons et al., 2014; George et al., 2015). This evidence concerns the gene TP53 and cancer.